Mutual Funds take advantage of the IPO season
In the last one year, a whopping 1051 schemes have applied for IPOs, of which only 582 schemes are currently holding on to those IPOs’ shares.
Read moreCategory Archives: Mutual Fund Facts
In conversation with Raj Mehta, Fund Manager, PPFAS Mutual Fund
Parag Parikh Flexi Cap Fund plays various overarching themes through just one scheme, making it one of the most comprehensive yet rewarding offerings.
Read moreCan Pharma Funds continue their dream run in future?
The macro-economic risk in the pharma sector is comparatively lower than other sectors. This is because irrespective of how macroeconomic variables – interest rate, GDP and inflation – move, the need for medication and healthcare services is unaffected.
Read moreNippon India Pharma Fund: On a firm footing
Nippon India Pharma Fund appears well-positioned to take advantage of the under penetration of pharmaceuticals and healthcare services in India and other emerging markets. The fund’s penchant for companies catering to specialty businesses in the developed markets might prove handsomely rewarding in the long run.
Read moreWhat’s your excuse for not investing in global equity markets?
Investing in overseas markets helps you hold assets denominated in foreign currencies which, in a way, offers you a hedge against the potential weakness in the Rupee.
Read moreIn Conversation with Taher Badshah
Are you wondering why markets are unmoved by the second wave? To decode this rather mysterious market stoicism, we recently caught up a market veteran Taher Badshah, Director and CIO (equities), Invesco Mutual Fund.
Read more